Hims & Hers Health (HIMS) Current Assets (2019 - 2026)
Hims & Hers Health (HIMS) reported Current Assets of $1.0 billion for Q1 2026, up 133.88% on a YoY basis from $447.0 million in Q1 2025, and up 36.18% sequentially from $767.6 million in Q4 2025.
Hims & Hers Health (HIMS) Current Assets (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Current Assets data on file, last reported at $1.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 133.88% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 133.88% YoY), and the FY2025 full-year result was $767.6 million, up 93.93% from the prior year.
- Current Assets grew to $1.0 billion in Q1 2026, from $767.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $1.4 billion in Q2 2025 to a low of $216.6 million in Q4 2022.
- A 5-year average of $448.4 million and a median of $265.1 million in 2023 frame the typical range for Current Assets.
- Across the five-year window, Current Assets slumped 31.82% in 2022 and jumped 365.96% in 2025, its largest moves.
- Tracing HIMS's Current Assets over 5 years: stood at $216.6 million in 2022, then gained by 22.37% to $265.1 million in 2023, then jumped by 49.34% to $395.8 million in 2024, then surged by 93.93% to $767.6 million in 2025, then surged by 36.18% to $1.0 billion in 2026.
- Business Quant data shows HIMS's Current Assets at $1.0 billion in Q1 2026, $767.6 million in Q4 2025, and $845.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 2.87 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 6.53 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 1.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 767.64 Mn |
| Sep 30, 2025 | 845.26 Mn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 446.96 Mn |
| Dec 31, 2024 | 395.83 Mn |
| Sep 30, 2024 | 326.38 Mn |
| Jun 30, 2024 | 290.92 Mn |
| Mar 31, 2024 | 261.73 Mn |
| Dec 31, 2023 | 265.05 Mn |
| Sep 30, 2023 | 250.22 Mn |
| Jun 30, 2023 | 234.65 Mn |
| Mar 31, 2023 | 225.53 Mn |
| Dec 31, 2022 | 216.60 Mn |
| Sep 30, 2022 | 233.46 Mn |
| Jun 30, 2022 | 230.49 Mn |
| Mar 31, 2022 | 231.95 Mn |
| Dec 31, 2021 | 269.91 Mn |
| Sep 30, 2021 | 274.23 Mn |
| Jun 30, 2021 | 336.34 Mn |